DPCO / NPPA

DPCO / NPPA – Latest notifications

National Pharmaceutical Pricing Authority (NPPA)

National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

Drugs Prices Control Order, 1995 (DPCO)

The Drugs Prices Control Order, 1995 is an order issued by the Government of India under Sec. 3 of Essential Commodities Act, 1955 to regulate the prices of drugs. The Order interalia provides the list of price controlled drugs, procedures for fixation of prices of drugs, method of implementation of prices fixed by Govt., penalties for contravention of provisions etc. For the purpose of implementing provisions of DPCO, powers of Govt. have been vested in NPPA.

What is ceiling price ? – In the case of each bulk drug, which is under price control a single maximum selling price is fixed that is applicable throughout the country.

What is retail price ? – A retail price is a price at which a formulation / medicine is sold to a consumer/user. The manufacturer of the formulation is required to print such a price on the label of the product. In case of controlled formulations the retail price is a price arrived at or fixed in accordance with the provisions of Drugs (Prices Control) Order, 1995.

What is Pro-rate pricing ? -NPPA has issued notification on pro -rata pricing on 27.01.98. According to this notification, the manufacturers of all the scheduled formulation pack sizes different from the notified pack sizes under sub- paragraphs (1) and (2) of the paragraph 9 of the DPCO,  1995, shall have to work out the price for such pack sizes, in respect of tablets and capsules of the same strength or composition packed in different strips or blisters, on pro-rata basis of the latest ceiling price fixed for such formulations under sub-paragraphs (1) and (2) of para 9 of the DPCO,  1995. This was done to ensure that :-
1. manufacturers are not forced to approach frequently for price approvals for different pack sizes and
2. the manufacturers do not change the pack sizes in a bid to remain out of price control.
Every formulation of a bulk drug included under schedule 1 of DPCO, irrespective of pack size, strength, dosage form must be marketed only at price fixed by Government, with adjustment for pro-rata price wherever required. However, the manufacturers in the Small Scale Industry (SSI) category may avail exemption from seeking price fixation from NPPA in respect of Scheduled Formulations not covered under ceiling prices provided they have submitted a declaration to NPPA as per S.O.No.134(E) dated 2nd March, 1995 and obtained approval for the same from NPPA.


Drugs (Prices Control) Order, 2013 (DPCO)

Drugs (Prices Control) Order, 1995 (DPCO)


NPPA – Updated price list as on 01-04-2020

NPPA – Updated price list as on 07-02-2020

NPPA – Form-IV Performa


Latest Notifications…..

S.O. 3322 (E) dt 25-09-2020 – Price Cap for Medical Liquid Oxygen and Oxygen Inhalation (Medicinal gas) in Cylinder

S.O. 3319 (E) dt 25-09-2020 -NPPA has fixed retail prices of 26 formulations under Drugs (Prices Control) Order, 2013 relating to 78th Authority meeting dated 14.09.2020

Office memorandum dt 25-09-2020 – Clarification regarding revision of Ceiling Prices of Orthopaedic Knee Implants for the year 2020

NPPA order dt 24-09-2020 – for submission of data by manufacturers and re-fillers of medical oxygen

S.O. 3147(E) 15-09-2020 – Notification regarding ceiling price fixation revision of orthopedic Knee Implants for Knee Replacement System

S.O. No. 2896 dt 27-08-2020 – NPPA has fixed retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 relating to 77th Authority meeting dated 06.08.2020

S.O. 2822(E) dt-20-08-2020 – NPPA has fixed retail prices of 29 formulations under Drugs Prices Control Order 2013 relating to 77th Authority meeting dated 06.08.2020

NPPA Office memorandum dt. 14-08-2020 Guidelines for Discontinuation of Scheduled Formulation

S.O.-No.-2768-E-dated-14-08-2020- regarding prices of Knee implants extended upto 15-09-2020

S.O. 2293(E) dt. 10-07-2020 NPPA HAS FIXED RETAIL PRICES OF 7 FORMULATIONS UNDER DRUGS (PRICES CONTROL) ORDER, 2013 RELATING TO 76TH AUTHORITY MEETING DATED 22.06.2020

S.O. 2292(E) dt. 10-07-2020 REVISION OF CEILING PRICE OF 1 FORMULATION BASED ON REVIEW ORDER RELATING TO 76TH AUTHORITY MEETING DATED 22.06.2020

S.O. 2150 dt. 30-06-2020 – NPPA has fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013 relating to 76th Authority meeting dated 22.06.2020

NPPA Office Memorandum dt-03-06-2020 – regarding revised MRPs of N-95 masks

NPPA has invited comments on Draft guidelines dated 01-06-2020 for dealing cases of discontinuation of scheduled formulations under Para 21(2) of DPCO 2013.

NPPA has notified vide S.O.-1674 (E) 28-05-2020 NPPA has fixed revised retail prices of 40 formulation under Drugs (Prices Control) Order, 2013

NPPA has notified vide S.O.-No.-1232(E) dt-31-03-2020 All Medical devices will be governed under DPCO w.e.f. 01-04-2020

NPPA Order dated 25.03.2020 to maintain stock of Lopinavir and Ritonavir Tablets

NPPA has fixed retail price of 2 items (Stents) S.O.-1217-dt-25-03-2020-NPPA-has-fixed-revised-retail-prices-of-2-items-Stents-under-Drugs-Prices-Control-Order-2013

NPPA has revised price of 16 items (Ringer lactate) vide S.O. No. 1216 dt 25-03-2020 as per annual wholesale price Index WPI @ 1.88468 % increase

NPPA has revised price of 8 items (Glucose, Sod Chloride etc.) vide S.O. No. 1215 dt 25-03-2020 as per annual wholesale price Index WPI @ 1.88468 % increase

NPPA has revised price of 13 items ( Salicylic acid, Cal carbonate, Condom-etc ) vide S.O. No. 1214 dt 25-03-2020 as per annual wholesale price Index WPI @ 1.88468 % increase

NPPA has revised price of 856 formulations vide S.O. No. 1213 dt 25-03-2020 as per annual wholesale price Index WPI @ 1.88468 % increase

NPPA has fixed retail price of 17 drugs under Drugs Prices Control Order 2013 vide S.O. No.  (E) dated 07-02-2020.

NPPA has fixed retail price of 17 drugs under Drugs Prices Control Order 2013 vide S.O. No.  (E) dated 28-01-2020

NPPA has fixed retail price of 7 drugs under Drugs Prices Control Order 2013 vide S.O. No.  (E) dated 31-12-2019

NPPA has fixed revised retail prices of Digital dose counter Glenmark under Drugs Prices Control Order 2013 vide S.O. No.  (E) dated 18-12-2019

NPPA has fixed / revised retail prices of 21 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No.  (E) dated 13-12-2019

NPPA has fixed / revised retail prices of 12 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No.  (E) dated 14-11-2019 in relating to 70th authority meeting dated 30.10.2019

NPPA has fixed / revised retail prices of 14 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No. 4063 (E) dated 08-11-2019 in relating to 70th authority meeting dated 30.10.2019

NPPA has fixed / revised retail prices of 59 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No. 4062 (E) dated 08-11-2019 in relating to 70th authority meeting dated 30.10.2019

NPPA has fixed / revised retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No. 4061 (E) dated 08-11-2019 in relating to 70th authority meeting dated 30.10.2019

NPPA has fixed / revised retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 vide S.O. No. 4060 (E) dated 08-11-2019 in relating to 70th authority meeting dated 30.10.2019

Today’s popular post

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.